Laws and sections by number or title, due dates, pages, and updates.
Medplus Health Services Limited initiates a buyback of its fully paid-up equity shares from the open market through the stock exchanges. The company sets a maximum buyback price of Rs. 750 per share. The total buyback size must not exceed Rs. 130 Crores. The buyback opens on November 13, 2026. It closes on February 16, 2027, or earlier if the company reaches the maximum buyback size or completes the buyback as determined by the board. Nuvama Wealth Management Limited acts as the broker and manager for this process. The company conducts this buyback in accordance with the SEBI (Buy-Back of Securities) Regulations, 2018.
What you must do
Key dates
Who is affected
Thresholds
Ask about this notice
| Notice No. | 20261112-24 |
|---|---|
| Notice Date | 12 Nov 2026 |
| Category | Trading |
| Segment | Equity |
| Department | Listing Business Relationship |
| Subject | Buyback of the Equity shares of MEDPLUS HEALTH SERVICES LIMITED from Open Market through Stock Exchanges |
| Attachments | Public_Announcement |
Market Participants are hereby informed that MEDPLUS HEALTH SERVICES LIMITED has announced the buyback of its fully paid-up equity shares of face value of Rs. 2 /- each from the open market through the Stock Exchanges, in accordance with the SEBI (Buy-Back of Securities) Regulations, 2018 updated as of July 6, 2026, and Exchange Notice No. 20260731-9 dated July 31, 2026. The maximum buyback price shall not exceed Rs.750 /- (Indian Rupees Seven Hundred and Fifty Only) per Equity Share (“Maximum Buyback Price”), payable in cash, for an aggregate amount not exceeding ₹ 130.00 Crores/- (Indian Rupees One Hundred and Thirty Crores Only) (“Maximum Buyback Size”)
| Date of Opening of the Buyback | Friday, November 13, 2026 |
|---|---|
| Last Date for the Buyback | Earlier of: |
(a) Tuesday February 16, 2027 (that is within 66 working days from the date of the opening of the Buyback); or
(b) when the Company completes the Buyback by deploying the amount equivalent to the Maximum Buyback Size; or
(c) at such earlier date as may be determined by the Board (including a committee thereof, constituted by the Board or persons nominated by the Board / committee to exercise its powers, and /or the powers conferred by the Board resolution in relation to the Buyback), after giving notice of such earlier closure, subject to the Company having deployed an amount equivalent to the Minimum Buyback Size (even if the Maximum Buyback Size has not been reached or the Maximum Buyback Shares have not been bought back in accordance with SEBI Buyback Regulations), however, that all payment obligations relating to the Buyback shall be completed before the last date for the Buyback. |
Company’s Broker for buyback:
| Name of the Member | Clearing No |
|---|---|
| Nuvama Wealth Management Limited) | 121 |
In case of any queries /clarifications on the scheme of buyback, Trading Members may please contact the under mentioned persons:
Registrar to the Buyback:
KFin Technologies Limited
Address: Selenium, Tower B, Plot No-31 and 32,
Gachibowli, Financial District, Nanakramguda, Hyderabad - 500032, Rangareddy, Telangana
Tel: + +91-40-67162222 / 18003094001
Contact Person: Mr. Williams R
Email ID: medplus.buyback@kfintech.com
Website: www.kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
SEBI Registration Number: INR000000221
CIN: L72400MH2017PLC344072
Manager to the Buyback:
Nuvama Wealth Management Limited
Address: 801-804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex,
Bandra East, Mumbai - 400051Bandra (East), Mumbai 400 013, Maharashtra, India
Tel: +91 22 6623 3325
Contact Person: Gourav Rathi / Lokesh Shah
Email: ecm.corpfin@nuvama.com
Website: www.nuvama.com
SEBI Registration Number: INM000013004
CIN: L67110MH1993PLC344634
The Company:
MEDPLUS HEALTH SERVICES LIMITED Shrenik Soni Company Secretary and Compliance Officer Address: H. No : 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India Email: cs@medplusindia.com
Mangesh Tayde Vice President Listing Business Relationship November 12, 2026
